| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $162.6M | — | -10.3% |
| Cost of Revenue | $92.9M | — | -6.1% |
| Gross Profit | $69.7M | — | -15.4% |
| R&D Expense | $44.4M | — | +2.0% |
| SG&A Expense | $17.0M | — | +12.2% |
| Operating Income | -$31.7M | — | -61.6% |
| Pre-tax Income | -$40.9M | — | -51.7% |
| Income Tax | -$6.4M | — | -755.2% |
| Net Income | -$34.5M | — | -31.5% |
| EPS (Basic) | -$0.20 | — | -33.3% |
| EPS (Diluted) | -$0.20 | — | -33.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $67.6M | -29.9% | -5.2% |
| Accounts Receivable | $204.1M | -12.0% | -9.5% |
| Inventory | $81.5M | +3.4% | +2.3% |
| Current Assets | $408.5M | -10.1% | -3.9% |
| Total Assets | $1.16B | -4.3% | +2.0% |
| Current Liabilities | $298.8M | -5.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$22.0M | — | -522.2% |
| Capital Expenditures | $3.1M | — | -74.7% |
| Investing Cash Flow | -$3.1M | — | +74.7% |
| Financing Cash Flow | -$3.1M | — | -71.9% |
| Free Cash Flow | -$25.1M | — | -59.8% |
| -2.1% |
| Long-term Debt | $339.9M | -0.6% | -2.1% |
| Total Liabilities | $740.6M | -3.0% | -2.0% |
| Stockholders' Equity | $419.1M | -6.7% | +9.8% |